Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Douglas

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
British Journal of Pharmacology|October 1, 1989
Vascular activities of endothelin-1 and some alanyl substituted analogues in resistance beds of the ratM D Randall, S A Douglas, C R Hiley
Journal of Neuroendocrinology|December 3, 2010
Nicotinic stimulation of catecholamine synthesis and tyrosine hydroxylase phosphorylation in cervine adrenal medullary chromaffin cellsP J Knowles, S A Douglas, S J Bunn
British Journal of Pharmacology|August 26, 2000
Human urotensin-II is a potent spasmogen of primate airway smooth muscleD W Hay, M A Luttmann, S A Douglas
The Journal of Pharmacy and Pharmacology|August 1, 1989
Vascular smooth muscle function in rats with acute renal failureS A Douglas, C J Bowmer, M S Yates
European Journal of Pharmacology|October 20, 1992
Regional vasodilation to endothelin-1 is mediated by a non-ETA receptor subtype in the anaesthetized rat: effect of BQ-123 on systemic haemodynamic responsesS A Douglas, J D Elliott, E H Ohlstein
European Journal of Pharmacology|April 1, 1994
Functional evidence that balloon angioplasty results in transient nitric oxide synthase inductionS A Douglas, L M Vickery-Clark, E H Ohlstein
Journal of Hypertension|May 1, 1994
BQ-123, a selective endothelin subtype A-receptor antagonist, lowers blood pressure in different rat models of hypertensionS A Douglas, M Gellai, M Ezekiel, et al.
British Journal of Pharmacology|February 1, 1993
Endothelin-1 does not mediate hypoxic vasoconstriction in canine isolated blood vessels: effect of BQ-123S A Douglas, L M Vickery-Clark, E H Ohlstein
Journal of Cardiovascular Pharmacology|January 1, 1993
Antihypertensive effects of the endothelin receptor antagonist BQ-123 in conscious spontaneously hypertensive ratsE H Ohlstein, S A Douglas, M Ezekiel, et al.
British Journal of Pharmacology|August 22, 2000
Human urotensin-II is an endothelium-dependent vasodilator in rat small arteriesF E Bottrill, S A Douglas, C R Hiley, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
British Journal of Pharmacology|October 1, 1989
Vascular activities of endothelin-1 and some alanyl substituted analogues in resistance beds of the ratM D Randall, S A Douglas, C R Hiley
Journal of Neuroendocrinology|December 3, 2010
Nicotinic stimulation of catecholamine synthesis and tyrosine hydroxylase phosphorylation in cervine adrenal medullary chromaffin cellsP J Knowles, S A Douglas, S J Bunn
British Journal of Pharmacology|August 26, 2000
Human urotensin-II is a potent spasmogen of primate airway smooth muscleD W Hay, M A Luttmann, S A Douglas
The Journal of Pharmacy and Pharmacology|August 1, 1989
Vascular smooth muscle function in rats with acute renal failureS A Douglas, C J Bowmer, M S Yates
European Journal of Pharmacology|October 20, 1992
Regional vasodilation to endothelin-1 is mediated by a non-ETA receptor subtype in the anaesthetized rat: effect of BQ-123 on systemic haemodynamic responsesS A Douglas, J D Elliott, E H Ohlstein
European Journal of Pharmacology|April 1, 1994
Functional evidence that balloon angioplasty results in transient nitric oxide synthase inductionS A Douglas, L M Vickery-Clark, E H Ohlstein
Journal of Hypertension|May 1, 1994
BQ-123, a selective endothelin subtype A-receptor antagonist, lowers blood pressure in different rat models of hypertensionS A Douglas, M Gellai, M Ezekiel, et al.
British Journal of Pharmacology|February 1, 1993
Endothelin-1 does not mediate hypoxic vasoconstriction in canine isolated blood vessels: effect of BQ-123S A Douglas, L M Vickery-Clark, E H Ohlstein
Journal of Cardiovascular Pharmacology|January 1, 1993
Antihypertensive effects of the endothelin receptor antagonist BQ-123 in conscious spontaneously hypertensive ratsE H Ohlstein, S A Douglas, M Ezekiel, et al.
British Journal of Pharmacology|August 22, 2000
Human urotensin-II is an endothelium-dependent vasodilator in rat small arteriesF E Bottrill, S A Douglas, C R Hiley, et al.
Pageof 7